Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Eikon Therapeutics, Inc. (EIKN) | Director | Feb 4, 2026 | Mar 4, 2026 |
| Merck & Co. (MRK) | Former Executive Chair, Director | Nov 5, 2009 | Nov 8, 2022 |
Also a director at
Merck & Co. (MRK) (no filing in the last 18 months)
Recent filings
The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Feb 4, 2026, Eikon Therapeutics, Inc.: bought 111,111 shares for $2.0M. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.